Related references
Note: Only part of the references are listed.Risk and predictive factors for severe dengue infection: A systematic review and meta-analysis
Kangzhuang Yuan et al.
PLOS ONE (2022)
Combining rapid diagnostic tests to estimate primary and post-primary dengue immune status at the point of care
Joseph R. Biggs et al.
PLOS NEGLECTED TROPICAL DISEASES (2022)
Performance Evaluation of a Dengue IgG Rapid Diagnostic Test Designed to Determine Dengue Serostatus as Part of Prevaccination Screening
Vasco Liberal et al.
MICROBIOLOGY SPECTRUM (2022)
Original Evaluation of a new point-of-care test to determine prior dengue infection for potential use in pre-vaccination screening
Jedas Veronica Daag et al.
CLINICAL MICROBIOLOGY AND INFECTION (2021)
Multiplex detection of antibodies to Chikungunya, O'nyong-nyong, Zika, Dengue, West Nile and Usutu viruses in diverse non-human primate species from Cameroon and the Democratic Republic of Congo
Raisa Raulino et al.
PLOS NEGLECTED TROPICAL DISEASES (2021)
Risk predictors of progression to severe disease during the febrile phase of dengue: a systematic review and meta-analysis
Sorawat Sangkaew et al.
LANCET INFECTIOUS DISEASES (2021)
Dengue pre-vaccination screening test evaluation for the use of dengue vaccine in an endemic area
Umaporn Limothai et al.
PLOS ONE (2021)
Effectiveness of a single-dose mass dengue vaccination in Cebu, Philippines: A case-control study
Michelle Ylade et al.
VACCINE (2021)
Adapting Rapid Diagnostic Tests to Detect Historical Dengue Virus Infections
Fernando Echegaray et al.
FRONTIERS IN IMMUNOLOGY (2021)
Clinical signs and symptoms associated with WHO severe dengue classification: a systematic review and meta-analysis
Tha Pyai Htun et al.
EMERGING MICROBES & INFECTIONS (2021)
Ethics of a partially effective dengue vaccine: Lessons from the Philippines
Scott B. Halstead et al.
VACCINE (2020)
Accuracy and efficacy of pre-dengue vaccination screening for previous dengue infection with five commercially available immunoassays: a retrospective analysis of phase 3 efficacy trials
Carlos A. Diaz Granados et al.
LANCET INFECTIOUS DISEASES (2020)
Enzyme-linked immunosorbent assays using virus-like particles containing mutations of conserved residues on envelope protein can distinguish three flavivirus infections
Wen-Yang Tsai et al.
EMERGING MICROBES & INFECTIONS (2020)
Deliberations of the Strategic Advisory Group of Experts on Immunization on the use of CYD-TDV dengue vaccine
Annelies Wilder-Smith et al.
LANCET INFECTIOUS DISEASES (2019)
Pre-vaccination screening strategies for the use of the CYD-TDV dengue vaccine: A meeting report
A. Wilder-Smith et al.
VACCINE (2019)
A review of Dengvaxia?: development to deployment
Stephen J. Thomas et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2019)
Rapid diagnostic tests for determining dengue serostatus: a systematic review and key informant interviews
R. Luo et al.
CLINICAL MICROBIOLOGY AND INFECTION (2019)
Combination of Nonstructural Protein 1-Based Enzyme-Linked Immunosorbent Assays Can Detect and Distinguish Various Dengue Virus and Zika Virus Infections
Jasmine Tyson et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2019)
Dengue infection and advances in dengue vaccines for children
Scott B. Halstead et al.
LANCET CHILD & ADOLESCENT HEALTH (2019)
Evaluation of rapid diagnostic tests and conventional enzyme-linked immunosorbent assays to determine prior dengue infection
Matthew Bonaparte et al.
JOURNAL OF TRAVEL MEDICINE (2019)
Comparison of Four Serological Methods and Two Reverse Transcription-PCR Assays for Diagnosis and Surveillance of Zika Virus Infection
Angel Balmaseda et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2018)
Development of an anti-dengue NS1 IgG ELISA to evaluate exposure to dengue virus
Eduardo J. M. Nascimento et al.
JOURNAL OF VIROLOGICAL METHODS (2018)
Effect of Dengue Serostatus on Dengue Vaccine Safety and Efficacy
S. Sridhar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Dengue vaccine: reliably determining previous exposure
Kevin K. Arien et al.
LANCET GLOBAL HEALTH (2018)
Potent Neutralizing Human Monoclonal Antibodies Preferentially Target Mature Dengue Virus Particles: Implication for Novel Strategy for Dengue Vaccine
Wen-Yang Tsai et al.
JOURNAL OF VIROLOGY (2018)
T Cell Responses to Nonstructural Protein 3 Distinguish Infections by Dengue and Zika Viruses
Bobby Brooke Herrera et al.
MBIO (2018)
Seroprevalence of dengue virus in two districts of Kaohsiung City after the largest dengue outbreak in Taiwan since World War II
Jih-Jin Tsai et al.
PLOS NEGLECTED TROPICAL DISEASES (2018)
Impact of Dengue Vaccination on Serological Diagnosis: Insights From Phase III Dengue Vaccine Efficacy Trials
Eric Plennevaux et al.
CLINICAL INFECTIOUS DISEASES (2018)
Antibody-based assay discriminates Zika virus infection from other flaviviruses
Angel Balmaseda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Live-attenuated tetravalent dengue vaccines: The needs and challenges of post-licensure evaluation of vaccine safety and effectiveness
Ole Wichmann et al.
VACCINE (2017)
Estimation of parameters related to vaccine efficacy and dengue transmission from two large phase III studies
Laurent Coudeville et al.
VACCINE (2016)
Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic Disease
S. R. Hadinegoro et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
A Shorter Time Interval Between First and Second Dengue Infections Is Associated With Protection From Clinical Illness in a School-based Cohort in Thailand
Kathryn B. Anderson et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
The global distribution and burden of dengue
Samir Bhatt et al.
NATURE (2013)
Symptomatic Versus Inapparent Outcome in Repeat Dengue Virus Infections Is Influenced by the Time Interval between Infections and Study Year
Magelda Montoya et al.
PLOS NEGLECTED TROPICAL DISEASES (2013)
Virus and antibody dynamics in acute West Nile virus infection
Michael P. Busch et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Antibodies to envelope glycoprotein of dengue virus during the natural course of infection are predominantly cross-reactive and recognize epitopes containing highly conserved residues at the fusion loop of domain II
Chih-Yun Lai et al.
JOURNAL OF VIROLOGY (2008)
Genetic and serologic properties of zika virus associated with an epidemic, Yap State, Micronesia, 2007
Robert S. Lanciotti et al.
EMERGING INFECTIOUS DISEASES (2008)
Slower rates of clearance of viral load and virus-containing immune complexes in patients with dengue hemorrhagic fever
Wei-Kung Wang et al.
CLINICAL INFECTIOUS DISEASES (2006)
Serotype-specific detection of dengue viruses in a fourplex real-time reverse transcriptase PCR assay
BW Johnson et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2005)
Comparison of capture immunoglobulin M (IgM) and IgG enzyme-linked immunosorbent assay (ELISA) and nonstructural protein NS1 serotype-specific IgG ELISA for differentiation of primary and secondary dengue virus infections
PY Shu et al.
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY (2003)
Share Paper
